SCHEMBL3295691

SCHEMBL3295691

O=C1CC(C2CC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4515462 0.89
SCHEMBL7648990 0.89
SCHEMBL8349202 0.89
SCHEMBL2074979 0.89 MAPK1 (0.35)
SCHEMBL2074977 0.89 MAPK1 (0.35)
SCHEMBL427801 0.87 ALDH1A1 (0.50)
SCHEMBL427737 0.84 ALDH1A1 (0.47)
Ethylene SCHEMBL8300809 0.81 MAPK1 (0.32)
Ethylene SCHEMBL7716211 0.81 MAPK1 (0.32)
SCHEMBL11442767 0.80 SHBG (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250092016-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES NOVARTIS AG (CH) 2025-03-20 US disclosed
EP-4373814-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES Novartis AG (CH) 2024-05-29 EP disclosed
CN-117651699-A Compounds and compositions for the treatment of coronavirus related diseases 诺华股份有限公司 2024-03-05 CN disclosed
WO-2023002409-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES NOVARTIS AG (CH) 2023-01-26 WO disclosed
US-7723371-B2 Microbiocides SYNGENTA CROP PROTECTION, INC. (US) 2010-05-25 US disclosed
US-20090054496-A1 MICROBIOCIDES SYNGENTA CROP PROTECTION, INC. (US) 2009-02-26 US disclosed
EP-1956909-A1 MICROBIOCIDES Syngeta Participations AG (CH) 2008-08-20 EP disclosed
WO-2007057139-A1 MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2007-05-24 WO disclosed